A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).
Clinical trial NCT02143882 · COMPLETED
Trial details
- NCT number
- NCT02143882
- Sponsor
- Public Health England
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2017-03-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.